[ U.S. CDMRP – Prostate Cancer Research Program Early Investigator Research Award ]
Event details
| Date | 04.06.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Prostate Cancer Research Program (PCRP) Awards. The PCRP Early Investigator Research Award supports prostate cancer-focused research opportunities for individuals in the early stages of their careers under the guidance of one or more designated Mentors. This opportunity allows early-career investigators to develop a research project, investigate a problem or question in prostate cancer research, and further their intellectual development as prostate cancer researchers of the future.
Key elements of this award mechanism are as follows:
Funding: max. $300’000
Duration: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The postdoc (PI) must have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training) as of March 31, 2021. Applications must include at least one Mentor, appropriate to the proposed research project.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of potential letter writers, and a biospecimen resource statement as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 04-Jun-2020, 5:00 p.m. EST
Full Application Deadline: 18-Jun-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PCRP-EIRA
Further information
FY20 Overarching Challenges
Key elements of this award mechanism are as follows:
- Principal Investigator: The postdoctoral investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of prostate cancer research.
- Mentor(s): Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in prostate cancer research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship.
- Research Approach: Proposed research ideas are required to address one or more of the FY20 PCRP Overarching Challenges, which are listed at the end of this announcement.
- Researcher Development Plan: The PI must outline an individualized, prostate cancer-focused researcher development plan, which should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project and foster the PI’s development as an independent prostate cancer researcher.
Funding: max. $300’000
Duration: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The postdoc (PI) must have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training) as of March 31, 2021. Applications must include at least one Mentor, appropriate to the proposed research project.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of potential letter writers, and a biospecimen resource statement as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 04-Jun-2020, 5:00 p.m. EST
Full Application Deadline: 18-Jun-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PCRP-EIRA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-PCRP-EIRA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 Overarching Challenges
- Improve the quality of life for survivors of prostate cancer
- Develop treatments that improve outcomes for men with lethal prostate cancer
- Reduce lethal prostate cancer in people of African descent, Veterans, and high-risk and underserved populations
- Define the biology of lethal prostate cancer to reduce death
Practical information
- General public
- Free